Clin2
NCT07874932Possibly a fitNot yet recruiting

Semaglutide effects on runners' body and performance

Caloric RestrictionBody CompositionPerformance

Treatments studied

This study tests if semaglutide, a medication used for diabetes and weight loss, changes body composition (muscle vs. fat) and running performance in healthy, experienced runners. It may help understand how this drug affects athletes.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
41 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • You are a healthy runner or triathlete with at least 5 years of training experience.
  • You train more than 10 hours per week.
  • You are between 18 and 45 years old.
  • Your body mass index (BMI) is between 21 and 26.
  • You do not have any chronic diseases or take regular medications (occasional pain relievers or allergy meds are okay).
  • If you are female: not pregnant, not using hormonal birth control for the last 6 months, and have regular menstrual cycles.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07874971Not yet recruiting
Semaglutide effects on body and performance in athletes

This study tests whether a short course of semaglutide (a medication used for diabetes and weight loss) changes body composition and exercise performance in healthy, experienced endurance athletes. It may help understand how this drug affects athletes.

Copenhagen
NCT07272343Recruiting· Phase 4
Semaglutide vs. diet changes for new type 2 diabetes

This study compares a weekly injection called semaglutide with a calorie-restricted diet to see which helps control blood sugar better. If you have just been diagnosed with type 2 diabetes and have overweight, this trial might help you choose a treatment path.

Jiangxi, Nanchang
NCT06909006Not yet recruiting· Phase 3
Semaglutide for adults with type 1 diabetes and overweight

This study tests whether semaglutide, a medicine that helps control blood sugar and reduce weight, can benefit adults with type 1 diabetes who are overweight. If you qualify, you may receive the drug or a placebo, and the study team will monitor your health closely.

Hillerød, Denmark
NCT07136714Recruiting· Phase 4
Semaglutide for depression in people with overweight

This study tests whether a weekly injection of semaglutide (a medication used for weight loss and diabetes) can help reduce symptoms of depression in people who have major depressive disorder and are overweight or obese.

Hillerød, Denmark
NCT06825793Not yet recruiting
Semaglutide for weight loss in obesity

This study tests a medication called semaglutide (a once-weekly injection) to help people with obesity lose weight. It is for adults who have already tried lifestyle changes without success.

NCT07323134Not yet recruiting
Semaglutide and gut bacteria in people with obesity

This study tests whether a medication called semaglutide (which helps with weight loss) can change the bacteria in your gut, which might play a role in weight regulation. By participating, you may receive a treatment that could help you lose weight while researchers learn more about how it works.

Hear when a new Body Composition trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.